Myocardial Protection with Phosphocreatine in High-Risk Cardiac Surgery Patients: A Randomized Trial
This study tested if phosphocreatine (PCr) reduces troponin I levels in cardiac surgery patients with prolonged aortic clamping and cardiopulmonary bypass. Although PCr was safely administered, it did not lead to a decrease in troponin I concentration or improve other clinical outcomes after surgery.